Trials / Conditions / BRCA 2 Gene Mutation

BRCA 2 Gene Mutation

5 registered clinical trials studyying BRCA 2 Gene Mutation — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Prospective CohorT Study of HandX - Assisted ENdoscopic MAstectomy: Feasibility and Safety (ATHENA I Study) NCT07292246	Vasileios Kalles	N/A
Unknown	A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients NCT04556292	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	Phase 2
Completed	Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Tre NCT02000622	AstraZeneca	Phase 3
Terminated	A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Canc NCT02034916	Pfizer	Phase 2
Completed	A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patien NCT01945775	Pfizer	Phase 3